At ENTA, we’re constantly monitoring and adjusting our protocols to make sure we are safely and effectively providing the care you need. For more information on how ENTA is taking extra precautions to provide the safest environment possible during the COVID-19 pandemic, please click here.
08/22/2012 in press release
Contact: Jason Campbell
Manager, Marketing and Special Events
ENT and Allergy Associates®, LLP Physicians Once Again Recognized as ‘Best in Class’
Well over a dozen ENTA Clinicians Voted Top Docs
Tarrytown, NY –August 20th, 2012. As an ENT and Allergy Associates physician, being the best at what you do means many important things; like delivering superior patient healthcare, championing the detection and prevention of dread diseases and pioneering new procedures and protocols.
Being the best can also mean acknowledgement as such by one’s own clinical peers; which is exactly what has been happening year after year for the superb physicians of ENT and Allergy Associates (ENTA). In fact, since January of this year alone, 19 of their ranks have achieved ‘Top Doc’ status in various publications. Specifically:
In this year’s 11th Edition of America’s Top Doctors, Jonathan Aviv, MD was recognized as a top doctor in Otolaryngology and Jay Dolitsky, MD was recognized as a top doctor in Pediatric Otolaryngology.
New York Magazine recently released its latest annual best doctors list, and ENTA Otolaryngologists David Godin, MD, Steven Sacks, MD, Jason Surow, MD, Jonathan Aviv, MD, Joseph Feghali, MD, and Pediatric Otolaryngologist Jay Dolitsky, MD were honored.
The 15th edition of the Castle Connolly Guide Top Doctors: New York Metro Area proudly noted Otolaryngologists Michael Gordon, MD, Steven Goldstein, MD, Jonathan Aviv, MD, Robert Green, MD, Steven Kase, MD, Hyman Ryback, MD, Steven Sacks, MD, Abraham Sinnreich, MD, Jason Surow, MD, Stanley Yankelowitz, MD, and for Pediatric Otolaryngology- Jay Dolitsky, MD and Michael Mendelsohn, MD.
Hudson Valley Magazine published their register of Top Doctors and recognized ENTA’s George Pazos, MD, Richard DeMaio, MD and Allergist Peter Logalbo, MD.
Michael Gordon, MD, Michael Mendelsohn, MD and Warren Zelman, MD were tapped by Newsday as Long Island’s top doctors.
Over in New Jersey, David Bough, MD and Jason Surow, MD were named top doctors in 201 Magazine.
And in Westchester County, Mark Fox, MD and Matthew Kates, MD were noted as best in class by Westchester Magazine.
The selection process varies from publication to publication, but in every case it begins with the distribution of thousands of surveys to physicians and healthcare professionals. Each is then asked to identify doctors of excellence in varying specialties in their region. What follows is peer nomination, extensive and careful review, final screening by a doctor-directed research team and accolade.
"At ENTA, we make it our business to identify and attract the best physicians from leading institutions across the nation”, noted Wayne Eisman, MD, President of ENTA. "This latest round of ‘top doc’ recognition is both very gratifying and also reinforces that the depth and breadth of medical expertise at ENTA is exceptional. We are extremely proud of one and all."
To learn more about the benefits of ENT and Allergy Associates, or to conveniently find an ENT doctor or Allergy Doctor and then easily book an appointment at the nearest New York (NY) or New Jersey (NJ) location, please visit www.entandallergy.com.
Each ENT and Allergy Associates clinical location provides access to a full complement of services, including General Adult and Pediatric ENT, Voice and Swallowing, Facial Plastics and Reconstructive Surgery, Disorders of the Inner Ear and Dizziness, Asthma, Clinical Immunology, Diagnostic Audiology, Hearing Aid dispensing, Sleep and CT Services. ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and esophageal cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cancer. The Practice has also expanded its clinical capabilities to include advanced Immunodeficiency trials.